Loading…
DIA Europe 2019 has ended
avatar for Wendy Huisman

Wendy Huisman

Vigifit
Wendy worked the last 15 years as (deputy) EU QPPV for Teva. She gained broad experience in a pharmacovigilance in complex organisations. Starting in 2005 Wendy built the pharmacovigilance working group of Medicines for Europe from almost nothing to the respected counterpart for the EMA and other industry associations as it is now. Wendy was one of the important initiators of for example the waiving of short term PSURS for generics, harmonized birthdates for PSURs (pre-legislation) and the extended introduction of signal detection for all products in Eudravigilance (2018). Keywords are reduction of duplication, challenge, pragmatic approaches. In 2018 Wendy started working independently as pharmacovigilance consultant / EU QPPV.

My Speakers Sessions

Thursday, February 7
 

12:00